New Desensitization Strategy: Daratumumab for Highly Sensitized Pediatric Heart Transplant Candidate-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

New Desensitization Strategy: Daratumumab for Highly Sensitized Pediatric Heart Transplant Candidate

Published:2023-09-25 Issue:10 Volume:107 Page:e271-e272
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Baez Hernandez Nathanya¹²,Butts Ryan¹²,Radel Laura¹²,Bano Maria¹²,Lantz Jodie¹²,Davies Ryan¹²³,Lacelle Chantale⁴,Iqbal Mehreen¹²,Ellimuttil Tracey⁵

Affiliation:

1. Department of Pediatric Cardiology, Children’s Health, Dallas, TX.

2. Division of Pediatrics, University of Texas Southwestern, Dallas, TX.

3. Department of Cardiovascular and Thoracic Surgery, UT Southwestern Medical Center, Dallas, TX.

4. Department of Pathology, UT Southwestern Medical Center, Dallas, TX.

5. Department of Pharmacy, Children’s Health, Dallas, TX.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference5 articles.

1. Daratumumab provides transient response of antibody mediated rejection post pediatric orthotopic heart transplantation.;Fenton;J Heart Lung Transplant,2022

2. Daratumumab for antibody-mediated rejection in heart transplant-a novel therapy: successful treatment of antibody-mediated rejection.;Aguilera Agudo;Transplantation,2021

3. Use of daratumumab for desensitization prior to cardiac transplantation: a case report.;Curtis;J Heart Lung Transplant,2021

4. Daratumumab in sensitized kidney transplantation: potentials and limitations of experimental and clinical use.;Kwun;J Am Soc Nephrol,2019

5. Daratumumab use prior to kidney transplant and T cell-mediated rejection: a case report.;Scalzo;Am J Kidney Dis,2023

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in understanding and managing pediatric heart failure and transplant;Current Opinion in Pediatrics;2024-08-13

2. Open-Label Phase 1/2 Study of Daratumumab-Based Desensitization Before Kidney Transplantation;Kidney International Reports;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3